281 related articles for article (PubMed ID: 31687650)
1. Effect of Denosumab on Femoral Periprosthetic BMD and Early Femoral Stem Subsidence in Postmenopausal Women Undergoing Cementless Total Hip Arthroplasty.
Aro HT; Nazari-Farsani S; Vuopio M; Löyttyniemi E; Mattila K
JBMR Plus; 2019 Oct; 3(10):e10217. PubMed ID: 31687650
[TBL] [Abstract][Full Text] [Related]
2. A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty.
Aro E; Moritz N; Mattila K; Aro HT
J Biomech; 2018 Jun; 75():35-45. PubMed ID: 29747966
[TBL] [Abstract][Full Text] [Related]
3. Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty.
Nagoya S; Tateda K; Okazaki S; Kosukegawa I; Shimizu J; Yamashita T
Eur J Orthop Surg Traumatol; 2018 Dec; 28(8):1601-1607. PubMed ID: 29774416
[TBL] [Abstract][Full Text] [Related]
4. Denosumab in Cementless Total Hip Arthroplasty: Multivariate Reanalysis of 3D Femoral Stem Migration and the Influence on Outliers.
Finnilä S; Löyttyniemi E; Aro HT
JBMR Plus; 2022 Feb; 6(2):e10588. PubMed ID: 35229065
[TBL] [Abstract][Full Text] [Related]
5. Preventing Loss of Femoral Periprosthetic Bone Mineral Density in Cementless Total Hip Arthroplasty Using a Tapered Wedge Stem: A Retrospective, Cohort Study in Osteoporotic Patients Treated with Denosumab.
Kamo K; Kijima H; Okuyama K; Kawano T; Seki N; Sato C; Kido T; Miyakoshi N
Cureus; 2024 May; 16(5):e59908. PubMed ID: 38721477
[TBL] [Abstract][Full Text] [Related]
6. Contributing factors to the initial femoral stem migration in cementless total hip arthroplasty of postmenopausal women.
Nazari-Farsani S; Vuopio M; Löyttyniemi E; Aro HT
J Biomech; 2021 Mar; 117():110262. PubMed ID: 33508723
[TBL] [Abstract][Full Text] [Related]
7. Volumetric Bone Mineral Density in Cementless Total Hip Arthroplasty in Postmenopausal Women: Effects on Primary Femoral Stem Stability and Clinical Recovery.
Aro HT; Engelke K; Mattila K; Löyttyniemi E
J Bone Joint Surg Am; 2021 Jun; 103(12):1072-1082. PubMed ID: 33750747
[TBL] [Abstract][Full Text] [Related]
8. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss.
Rahmy AI; Gosens T; Blake GM; Tonino A; Fogelman I
Osteoporos Int; 2004 Apr; 15(4):281-9. PubMed ID: 14661072
[TBL] [Abstract][Full Text] [Related]
9. [Effects of denosumab on bone mineral density around proximal femoral prosthesis after total hip replacement in postmenopausal osteoporotic patients].
Ning WH; Xu GZ; Wang JW
Zhongguo Gu Shang; 2023 Nov; 36(11):1041-5. PubMed ID: 38012872
[TBL] [Abstract][Full Text] [Related]
10. High periprosthetic bone mineral density measured in immediate postoperative period may not guarantee less periprosthetic bone loss in the proximal femur after cementless total hip arthroplasty - A retrospective study.
Fu G; Ma Y; Liao J; Xue Y; Li M; Li Q; Deng Z; Zheng Q
Arthroplasty; 2020 Jan; 2(1):2. PubMed ID: 35236466
[TBL] [Abstract][Full Text] [Related]
11. Bone Mineral Density and Cortical-Bone Thickness of the Distal Radius Predict Femoral Stem Subsidence in Postmenopausal Women.
Nazari-Farsani S; Vuopio ME; Aro HT
J Arthroplasty; 2020 Jul; 35(7):1877-1884.e1. PubMed ID: 32205004
[TBL] [Abstract][Full Text] [Related]
12. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Bone HG; Wagman RB; Brandi ML; Brown JP; Chapurlat R; Cummings SR; Czerwiński E; Fahrleitner-Pammer A; Kendler DL; Lippuner K; Reginster JY; Roux C; Malouf J; Bradley MN; Daizadeh NS; Wang A; Dakin P; Pannacciulli N; Dempster DW; Papapoulos S
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):513-523. PubMed ID: 28546097
[TBL] [Abstract][Full Text] [Related]
13. Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: A systematic review and network meta-analysis.
Hatano M; Koizumi Y; Yamamoto N; Miyoshi K; Kawabata K; Tanaka T; Tanaka S; Shiroshita A; Kataoka Y
J Orthop Sci; 2024 Feb; ():. PubMed ID: 38342711
[TBL] [Abstract][Full Text] [Related]
14. Denosumab Prevents Early Periprosthetic Bone Loss After Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial.
Nyström A; Kiritopoulos D; Ullmark G; Sörensen J; Petrén-Mallmin M; Milbrink J; Hailer NP; Mallmin H
J Bone Miner Res; 2020 Feb; 35(2):239-247. PubMed ID: 31589776
[TBL] [Abstract][Full Text] [Related]
15. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients.
Aro HT; Alm JJ; Moritz N; Mäkinen TJ; Lankinen P
Acta Orthop; 2012 Apr; 83(2):107-14. PubMed ID: 22489886
[TBL] [Abstract][Full Text] [Related]
16. The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.
Sköldenberg OG; Salemyr MO; Bodén HS; Ahl TE; Adolphson PY
J Bone Joint Surg Am; 2011 Oct; 93(20):1857-64. PubMed ID: 22012522
[TBL] [Abstract][Full Text] [Related]
17. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Roux C; Hofbauer LC; Ho PR; Wark JD; Zillikens MC; Fahrleitner-Pammer A; Hawkins F; Micaelo M; Minisola S; Papaioannou N; Stone M; Ferreira I; Siddhanti S; Wagman RB; Brown JP
Bone; 2014 Jan; 58():48-54. PubMed ID: 24141036
[TBL] [Abstract][Full Text] [Related]
18. Skeletal responses to romosozumab after 12 months of denosumab.
McClung MR; Bolognese MA; Brown JP; Reginster JY; Langdahl BL; Shi Y; Timoshanko J; Libanati C; Chines A; Oates MK
JBMR Plus; 2021 Jul; 5(7):e10512. PubMed ID: 34258507
[TBL] [Abstract][Full Text] [Related]
19. Lower periprosthetic bone loss and good fixation of an ultra-short stem compared to a conventional stem in uncemented total hip arthroplasty.
Salemyr M; Muren O; Ahl T; Bodén H; Eisler T; Stark A; Sköldenberg O
Acta Orthop; 2015; 86(6):659-66. PubMed ID: 26134386
[TBL] [Abstract][Full Text] [Related]
20. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.
Lewiecki EM; Miller PD; McClung MR; Cohen SB; Bolognese MA; Liu Y; Wang A; Siddhanti S; Fitzpatrick LA;
J Bone Miner Res; 2007 Dec; 22(12):1832-41. PubMed ID: 17708711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
